Urolesan (wild fruit carrots, hop cones) capsules №40

Description

Urolesan (wild fruit carrots, hop cones) capsules №40

Composition

Active ingredients: 1 capsule contains Urolesan thick extract obtained from a mixture of liquid extracts from Daucus carota L., fructus (wild fruit carrots) (1: 1), Humulus lupulus L., flos (hop cones) (1: 1), Oreganum vulgare L., herba (oregano) (1: 1) in the ratio 1 / 1,4 / 1, extractant – ethanol 96% v / v, in terms of 10% moisture – 10,70 mg, Mentha x piperita L., aetheroleum (peppermint oil) – 7.46 mg, Abies sibirica L., aetheroleum (Siberian fir oil) – 25.50 mg.

Excipients: magnesium aluminometasilicate; castor oil; heavy magnesium carbonate; talc; lactose monohydrate; edetate disodium (Trilon B); potato starch.

Dosage form

Capsules.

Main physical and chemical properties: hard gelatin capsules number “0”, body and green lid. Capsule content is a granular powder and / or compacted mass from yellow-gray to gray-brown color with a greenish tinge with splashes and the smell of peppermint and fir peppermint oils. The presence of agglomerates that crumble when pressed is allowed.

Pharmacotherapeutic group

Means used in urology.

ATX code G04B X.

Pharmacological properties

Combined drug of plant origin. Ingredients of Urolesan capsules reduce inflammation in the urinary tract and kidneys, promote increased blood circulation to the kidneys and liver, have diuretic, antibacterial, choleretic effect, form a protective colloid in the urine and normalize the tone of the smooth muscles of the upper urinary tract and upper urinary tract.

Urolesan capsules increases the excretion of urea and chlorides, helps to remove small stones and sand from the bladder and kidneys.

Indication:

• acute and chronic urinary tract and kidney infections (cystitis and pyelonephritis);
• urolithiasis and uric acid diathesis (prevention of concretions after their removal);
• chronic cholecystitis (including calculous), biliary dyskinesia, gallstone disease.

Contraindications

Urolesan capsules is not prescribed in case of hypersensitivity to the components of this drug (which in the past have already observed allergic reactivity to any of the components of this drug), allergies to plants of the Hemp family, plants of the Umbrella family, plants of the Lamb family, hyperacid stomach inflammation (gastritis with high acidity) , peptic ulcer, erosive lesions of the stomach, 12-duodenum. Do not use the drug in case of large stones (3 mm).

Care should be taken when prescribing Urolesan in the form of a syrup to people with diabetes mellitus, as well as to patients with high blood sugar (sugar syrup is present in the drug). Caution during use is also needed in patients with bronchial asthma due to the risk of developing bronchospasm (a sharp narrowing of the bronchi). Children under the age of 14 are prescribed a drug in liquid form (syrup or solution). The drug in the form of a syrup cannot be administered to children under two years of age. If necessary, use in children under seven years of age, Urolesan syrup is used.

Application during pregnancy and lactation

The appointment of this pharmacological agent during pregnancy, breastfeeding has not been studied, therefore, the use is contraindicated.

Method of administration and dosage

The drug Urolesan capsules should be taken orally before meals. A single dose, frequency of administration, duration of the course of treatment is determined by the doctor.

Dosage of capsules: the recommended dose for adults and children over the age of 14 is 1 capsule x 3 times / day. In acute conditions (including renal / hepatic colic), the duration of the course of treatment is 5–7 days, in chronic conditions – from seven days to a month. In the event of renal / hepatic colic, a single dose is allowed to be increased once to two capsules, and in subsequent doses, return to the standard single dose (one capsule).

Overdose

Signs of an overdose with Urolesan: possible vomiting, dizziness.

Overdose treatment: plentiful warm drink, intake of enterosorbent (activated carbon), rest, appointment of atropine sulfate (0.5-1 mg).

Side effects

Disorders from the digestive system: dyspeptic symptoms (heartburn, nausea, belching);

Disorders from the immune system: allergic manifestations in the form of itching, facial redness, skin rashes, angioedema (sore throat, shortness of breath, swelling of parts of the face, tongue), anaphylactic shock (severe itching of the skin, quickly spreading over the skin, sharp drop in blood pressure, vomiting, loose stools, laryngeal edema, noisy and labored breathing, pallor or cyanosis of the skin, a sharp narrowing of the bronchi and larynx, leading to acute difficulty in breathing, loss of consciousness, disorder of the vital organs);

Disorders from the central / peripheral nervous system: general weakness, dizziness, ataxia (impaired coordination of movements), headache, muscle tremor;

Disorders from the cardiovascular system: arterial hypotension / hypertension, bradycardia (slow heartbeat), pain in the heart.

Storage conditions and periods

Capsules should be stored in their original (factory) packaging, subject to temperature conditions (within 15-25 ° C), low humidity and no direct sunlight. The maximum shelf life differs for dosage forms (indicated on the package). Parents need to keep their children safe and restrict their access to medication.